JOURNAL OF CLINICAL LABORATORY ANALYSIS, cilt.23, sa.4, ss.244-248, 2009 (SCI-Expanded)
Background: Cancer antigen 125 (CA-125) is a tumor marker used for the diagnosis and monitoring of ovarian carcinoma. It can also be elevated in endometriosis, inflammations, and in nongynecological malignancies. Up to date, serum CA-125 levels in inflammatory bowel diseases (IBD) have not been studied before. Aim: To assess the levels of CA-125 in patients with ulcerative colitis (UC) and Crohn's disease (CD).